Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Mar 21, 2023 12:22pm
42 Views
Post# 35351457

RE:RE:RE:RE:RE:Who remembers

RE:RE:RE:RE:RE:Who remembers

Jonnyboy85 wrote: And with stage in total control of when and how much is drawn, you think if they use manipulative trading strategies to hold the share price back that stage will just go along with it in good faith?? You think that shareholders would approve it? You think management would approve it? Continue it? Newp, like I said, and even with regulatory barriers aside, they wouldn't bite the hand that feeds because they have zero control over how and when the draws take place, and Tripp already said it's going to be slow and steady to protect shareholder value. You must have selective comprehension lol only understand what best suits your shill narrative aye? You think the insider who wants to buy an additonal 10% stake thinks gem is about to sell them down? Think they would be voting up this financing? Lol so for the last time, no matter what account you want to bring it up through, it's a weak bash because it's actually a bullish af signal and it was after they postponed the vote on this that the stock doubled, it was a total power move by Tripp to not only show the interest in the companyby insiders and institutional investors but also show they didn't need it. But i guess thats why they call it a short and DISTORT, you take yhe good news and try to reshape it into bad news as you always do. Maybe make the coffee stronger tmrw

 


where did you get an insider wants to buy 10% of the company?

the quote is as follows again from the press release 
 

  1. Approval to issue common shares to a director, in excess of 10% of the issued and outstanding common shares, as conversion of short term notes.
that usually means they lent money to the company to continue operations and in Exchage will issue share.

or in exchange for unpaid wages they will take shares.

where did you come up with an insider wanting to buy 10%?
<< Previous
Bullboard Posts
Next >>